Unit Dose Manufacturing Market Report Scope & Overview:
The unit dose manufacturing market size was valued at USD 74.30 billion in 2024 and is expected to reach USD 172.96 billion by 2032, growing at a CAGR of 11.16% over the forecast period of 2025-2032.
The global unit dose manufacturing market is growing rapidly, owing to the increase in demand for precise dosing and patient safety, as unit dose formats are known to reduce medication errors and improve adherence, making it highly suitable among elderly patients and pediatric patients. The expansion of companies outsourcing manufacturing via CDMOs is another major factor that enables pharma companies to decrease costs, shorten the time-to-market, and concentrate on R&D. These factors are significantly attractive in unit dose manufacturing market trends among hospitals, pharmacies, and the nutraceutical sector.
For instance, in June 2024, global contract manufacturing revenues for unit dose formats rose by 8%, reflecting increasing pharmaceutical outsourcing to CDMOs for cost-efficiency and faster market entry.
Key Unit Dose Manufacturing Market Trends
-
Rising demand for unit dose packaging in pharmaceuticals, nutraceuticals, and diagnostics to improve dosage accuracy, reduce medication errors, and enhance patient adherence.
-
Increasing adoption of advanced packaging technologies, including pre-fillable syringes, blister packs, and stick packs with tamper-evident, child-resistant, and eco-friendly features.
-
Use of lightweight, sustainable materials and smart labeling solutions (QR codes, RFID, barcodes) for improved supply chain tracking, patient safety, and regulatory compliance.
-
Growing utilization in oral solid dosage forms, liquid formulations, injectables, and inhalables, expanding applications beyond traditional pills into biologics and personalized medicine.
-
Expansion of procurement by contract manufacturing organizations (CMOs), pharma companies, and hospitals, particularly across North America, Europe, and Asia-Pacific, due to outsourcing trends and regulatory pressure.
-
Integration of digital serialization, IoT-enabled packaging lines, and AI-driven quality control for real-time monitoring, predictive maintenance, and enhanced production efficiency in unit dose manufacturing.
Unit Dose Manufacturing Market Report Highlights
The U.S. unit dose manufacturing market was valued at USD 24.23 billion in 2024 and is expected to reach USD 55.59 billion by 2032, growing at a CAGR of 10.96% over 2025-2032. The U.S. unit dose manufacturing market is major due to large Consumption of pharmaceuticals and high prescription per capita, especially for chronic diseases and biologics. This has driven demand for sealed, single-use packaging. Based on recent unit dose manufacturing market analysis, hospitals, pharmacies, and long-term care facilities prefer the unit dose applications to address patient safety, adherence, and reduce inventory waste.
Unit Dose Manufacturing Market Growth Drivers:
-
Growth in Outsourced Manufacturing is Driving the Unit Dose Manufacturing Market Growth
Outsourced manufacturing (CDMOs/CMOs) penetration in the pharmaceutical industry will remain a high-impact rendering driver for the unit dose manufacturing market share. This trend enables CDMO-produced unit dose formats to enter the market more quickly, gain access to state-of-the-art technologies for unit doses, and scale to both clinical and commercial volumes with a higher overall percentage of the market.
For instance, in March 2025, CDMOs accounted for approximately 55% of global unit dose production volumes, highlighting the increasing reliance on outsourced manufacturing in the market.
Unit Dose Manufacturing Market Restraints:
-
Limited Shelf Life for Certain Dosage Forms is Hampering the Unit Dose Manufacturing Market Growth
limited shelf life of liquid and biologic unit dose formats limits the growth of the market since such products need to be stored under well-defined conditions, including controlled storage, cold chain logistics, and quick distribution. It limits scaling; parenteral and high-value biologics require more effort, translating to cost, whose marginal utility inhibits the unit dose growth rate despite growing international need.
Unit Dose Manufacturing Market Opportunities:
-
Integration Of Digital and Smart Packaging Drives Future Growth Opportunities for the Unit Dose Manufacturing Market
The growing demand for safer medical suctioning. Independent Pharmacies and healthcare facilities are focusing more and more on closed-system suctioning and disposable canisters to reduce the risk of contamination, help reduce the incidence of hospital-acquired infections (HAIs), and abide by stricter infection control guidelines. This paradigm shift offers significant growth possibilities to manufacturers of new-age, more hygienic, and affordable suction solutions globally.
For instance, in October 2024, a Pharma Intelligence survey reported that over 60% of pharmaceutical companies in North America and Europe planned or implemented IoT-enabled packaging to improve adherence.
Key Unit Dose Manufacturing Market Segment Analysis
-
By product, solid unit dose held the largest share of around 52.87%in 2024, and the liquid unit dose segment is expected to register the highest growth with a CAGR of 11.68%.
-
By sourcing, the outsourcing segment dominated the market with approximately 61.47% share in 2024, while in-house is expected to register the highest growth with a CAGR of 11.49%.
-
By packaging format, blister & strip packs accounted for the leading share of nearly 48.98% in 2024, while sachets, pouches & bottles are expected to register the highest growth with a CAGR of 11.58%.
-
By end user, the independent pharmacies segment led the market with about 40.80% share in 2024, while the hospitals segment is forecasted to grow the fastest at a CAGR of 12.07%.
By Product, Solid Unit Dose Leads the Market, While Liquid Unit Dose Registers Fastest Growth
The solid unit dose segment accounted for the highest revenue share of approximately 52.87% in 2024, owing to its cost-effectiveness, long shelf life, and easy handling. Pharmaceuticals, nutraceuticals, and OTC products mostly use tablets & capsules. In comparison, the liquid unit dose segment is anticipated to achieve the highest CAGR of nearly 11.68% during the 2025–2032 period, driven by increasing demand for prefilled syringes, BFS ampoules, and single-dose bottles in biologics, vaccines, and OTC products.
By Sourcing, the Outsourcing Segment dominates, while the In-house Segment Shows Rapid Growth
The Outsourcing segment held the largest revenue share of approximately 61.47% in 2024, as the growing dependence of pharmaceutical companies on CDMOs and contract manufacturers for low-cost, high-grade production. Outsourcing, therefore, is the preferred approach for global unit dose manufacturing due to key drivers, including shorter time-to-market. On the other hand, the In-house segment is predicted to grow at the strongest CAGR of approximately 11.49% during 2025–2032, driven by the pharmaceutical companies pouring money into developing in-house manufacturing for quality control, technology preservation, and quicker answers to shifts in demand.
By Packaging Format, Blister & Strip Packs Segment Lead, While Sachets, Pouches & Bottles Register Fastest Growth
The blister & strip packs segment accounted for the largest share of the unit dose manufacturing market with about 48.98%, owing to their low cost and high production rate, and storage life. Major driving factors are widespread adoption of oral solid drugs, nutraceuticals & OTC products, regulatory preference for unit dose safety, along with ease of distribution. In addition, the sachets, pouches & bottles segment is slated to grow at the fastest rate with a CAGR of around 11.58% throughout the forecast period of 2025–2032, driven by the increasing need for hygienic, disposable designs in nutraceuticals, OTC products, and rehydration solutions. This is mainly due to the growing demand among the rapidly growing on-the-go consumers and rapid penetration in emerging markets.
By End User, Independent Pharmacies Segment Lead, While the Hospitals Segment Grows the Fastest
The independent pharmacies segment held the largest revenue share of around 40.80% in the unit dose manufacturing market in 2024, owing to their expansive landscape and lean on individual preparation and patient protection. The independent pharmacy segment is a considerable factor in the demand for precision unit doses, due to their convenience and ability to ease inventory management. On the flip side, the hospitals segment, however, is projected to register the highest CAGR of around 12.07% during the forecast period of 2025 - 2032, as a result of the continued shift to unit dose formats for inpatient care, infection control, and medication safety. Regulatory diktats, imperative for accurate dosing, improved inventory management.
Asia Pacific Urine Testing Cups Market Insights
The Asia Pacific segment is projected to witness the fastest CAGR of 11.99% during the forecast period of 2025–2032, as a result of an increase in the demand for health care, the growth in pharmaceutical manufacturing and increasing awareness of medication safety. Importantly, burgeoning urbanization and rising populations in regions including China, India, and Southeast Asia continue to fuelled consumption of pharmaceuticals, OTC products, and nutraceuticals which will in turn create prolonged need for unit dose packaging formats like blisters, sachets and prefilled syringes. Moreover, the ascendance of CDMOs, cost-effective manufacturing, and substantial support from the government in the form of supportive regulations are fostering local production and adoption.
North America Urine Testing Cups Market Insights
North America accounted for the highest revenue share of approximately 38.72% in 2024 of the unit dose manufacturing market, owing to its pharma-friendly infrastructure, high-cost healthcare, and stringent regulations. The drivers include blister packaging, prefilled syringes, and parenteral unit dosing in hospitals, pharmacies, causing more use of CDMOs for manufacturing outsourcing, as patient safety, accurate dosing, and inventory become paramount. In addition, the use of advanced dispensing technology and an increased number of prescriptions, and an increase in biologics will continue to ensure North America remains a leading market for unit doses over a global perspective.
Europe Urine Testing Cups Market Insights
The Europe Unit Dose Manufacturing Market is growing steadily owing to its strong pharmaceutical industry, advanced manufacturing infrastructure, and high regulatory standards. The key drivers supporting the market expansion in the region include extensive usage of blister packs and parenteral unit doses, the adoption rate of CDMO services, rising demand for biologics & OTC products, and growing mandates by regional governments to ensure patient safety, coupled with precise dosing practices among others.
Latin America (LATAM) and Middle East & Africa (MEA) Urine Testing Cups Market Insights
The Latin American and MEA unit dose packaging market is growing owing to increasing consumption of pharmaceutical products, developing healthcare infrastructure, and surging incidence of chronic diseases. Modern healthcare facilities are being established by governments, and rising outsourcing to contract manufacturers is enhancing the uptake of cutting-edge unit dose options. These are some areas that offer a huge appetite for growth.
Competitive Landscape for the Unit Dose Manufacturing Market:
Catalent is a global leader in advanced drug development, delivery technologies, and contract manufacturing services. The company specializes in oral, injectable, and biologic formulations, supporting pharma and biotech clients with scalable, innovative solutions globally.
-
In February 2025, Catalent expanded its U.S. facility in Bloomington, Indiana, adding unit dose oral solid manufacturing lines to support increased demand for personalized medicine and biologics, enhancing production capacity and supply chain efficiency.
Recipharm is a leading pharmaceutical contract development and manufacturing organization (CDMO) based in Sweden. It provides comprehensive services from drug development to commercial manufacturing, including oral solids, sterile liquids, and inhalation products for global pharma companies.
-
In August 2024, Recipharm announced a strategic investment in a new sterile injectable unit dose facility in Sweden, aiming to increase commercial-scale production and strengthen its biologics and specialty drug portfolio for European markets.
PCI Pharma Services offers end-to-end pharmaceutical outsourcing solutions, including drug development, clinical and commercial manufacturing, packaging, and logistics. The company emphasizes quality, regulatory compliance, and personalized solutions for pharmaceutical and biotech clients globally.
-
In November 2024, PCI Pharma Services launched AI-driven smart packaging solutions for unit dose medications, integrating serialization, IoT tracking, and predictive quality monitoring to improve patient adherence and regulatory compliance globally.
Unit Dose Manufacturing Market Key Players:
Some of the medical suction device market companies are:
-
Catalent, Inc.
-
Recipharm AB
-
PCI Pharma Services
-
Aenova Group
-
Sharp Services, LLC
-
Unither Pharmaceuticals
-
Vetter Pharma International GmbH
-
Baxter BioPharma Solutions
-
Lonza Group Ltd.
-
Siegfried Holding AG
-
Alcami Corporation
-
DPT Laboratories
-
Klocke Group
-
Tapemark
-
PillPack
-
AptarGroup, Inc.
-
Stevanato Group
-
Glenmark Life Sciences
-
Sanofi Contract Manufacturing
-
CordenPharma
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 74.30 billion |
| Market Size by 2032 | USD 172.96 billion |
| CAGR | CAGR of 11.16% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Liquid Unit Dose, Solid Unit Dose, Others) • By Sourcing (In-house, Outsourcing) • By Packaging Format (Blister & Strip Packs, Sachets, Pouches & Bottles, Parenteral & Specialized Containers) • By End User (Independent Pharmacies, Long Term Care Facility, Hospitals, Others) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Poland, Russsia, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia,ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia Rest of Latin America) |
| Company Profiles | Catalent, Inc., Recipharm AB, PCI Pharma Services, Aenova Group, Sharp Services, LLC, Unither Pharmaceuticals, Vetter Pharma International GmbH, Baxter BioPharma Solutions, Lonza Group Ltd., Siegfried Holding AG, Alcami Corporation, DPT Laboratories, Klocke Group, Tapemark, PillPack, AptarGroup, Inc., Stevanato Group, Glenmark Life Sciences, Sanofi Contract Manufacturing, CordenPharma. and other players. |
Table of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product
2.3.2 Market Size By Sourcing
2.3.2 Market Size By Packaging Format
2.3.2 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Production Volume Trends (2020–2032)
4.1.1 Global and regional unit dose output volumes (pharma, nutraceuticals, animal health)
4.1.2 Growth rate comparison: in-house manufacturing vs contract manufacturing (CDMOs/CMOs)
4.1.3 Demand split: prescription products vs over-the-counter (OTC) products
4.2 Client Demographics and Utilization (2024)
4.2.1 Share of orders by company size (large pharma, mid-tier, startups)
4.2.2 Industry utilization patterns: pharma, biotech, nutraceuticals, veterinary health
4.2.3 Order volume trends by target market (domestic vs export production)
4.3 Manufacturing Ownership and Capacity Trends (2020–2024)
4.3.1 Distribution of facilities by ownership: company-owned vs third-party manufacturing
4.3.2 Number of new unit dose manufacturing facilities launched annually by region
4.3.3 Average facility size, production line count, and automation adoption rates
4.4 Pricing and Contract Structure Analysis (2024)
4.4.1 Price range per 1,000 units by dosage form (solid, liquid, semi-solid)
4.4.2 Cost comparison: small-batch vs high-volume manufacturing
4.4.3 Adoption of long-term supply agreements vs spot contracts
4.5 Cost Efficiency and Time-to-Market Benefits (2024)
4.5.1 Average cost savings using CDMOs vs maintaining in-house facilities
4.5.2 Average lead time from development to market launch (in-house vs outsourced)
4.5.3 Trends in rapid production technologies and small-batch flexibility
5. Unit Dose Manufacturing Market Segmental Analysis & Forecast, By Product, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Liquid Unit Dose
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Solid Unit Dose
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Others
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
6. Unit Dose Manufacturing Market Segmental Analysis & Forecast, By Sourcing, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 In-house
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Outsourcing
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
7. Unit Dose Manufacturing Market Segmental Analysis & Forecast, By Packaging Format, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Blister & Strip Packs
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Sachets, Pouches & Bottles
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Parenteral & Specialized Containers
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
8. Unit Dose Manufacturing Market Segmental Analysis & Forecast, By End User, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Independent Pharmacies
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Long Term Care Facility
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Hospitals
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Others
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
9. Unit Dose Manufacturing Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.2.3 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.2.4 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.2.5 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.2.6 Unit Dose Manufacturing Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.2.6.1.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.2.6.1.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.2.6.1.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.2.6.2.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.2.6.2.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.2.6.2.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.3.3 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.3.4 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.3.5 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.3.6 Unit Dose Manufacturing Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.3.6.1.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.3.6.1.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.3.6.1.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.3.6.2.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.3.6.2.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.3.6.2.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.3.6.3.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.3.6.3.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.3.6.3.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.3.6.4.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.3.6.4.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.3.6.4.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.3.6.5.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.3.6.5.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.3.6.5.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.3.6.6.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.3.6.6.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.3.6.6.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.3.6.7.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.3.6.7.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.3.6.7.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.3.6.8.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.3.6.8.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.3.6.8.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.4.3 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.4.4 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.4.5 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.4.6 Unit Dose Manufacturing Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.4.6.1.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.4.6.1.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.4.6.1.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.4.6.2.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.4.6.2.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.4.6.2.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.4.6.3.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.4.6.3.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.4.6.3.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.4.6.4.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.4.6.4.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.4.6.4.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.4.6.5.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.4.6.5.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.4.6.5.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.4.6.6.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.4.6.6.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.4.6.6.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.4.6.7.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.4.6.7.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.4.6.7.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.5.3 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.5.4 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.5.5 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.5.6 Unit Dose Manufacturing Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.5.6.1.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.5.6.1.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.5.6.1.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.5.6.2.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.5.6.2.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.5.6.2.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.5.6.3.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.5.6.3.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.5.6.3.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.5.6.4.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.5.6.4.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.5.6.4.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.5.6.5.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.5.6.5.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.5.6.5.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.6.3 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.6.4 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.6.5 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.6.6 Unit Dose Manufacturing Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.6.6.1.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.6.6.1.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.6.6.1.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.6.6.2.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.6.6.2.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.6.6.2.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.6.6.3.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.6.6.3.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.6.6.3.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.6.6.4.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.6.6.4.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.6.6.4.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.6.6.5.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.6.6.5.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.6.6.5.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Unit Dose Manufacturing Market Size & Forecast, By Product, 2021 – 2032
9.6.6.6.2 Unit Dose Manufacturing Market Size & Forecast, By Sourcing, 2021 – 2032
9.6.6.6.3 Unit Dose Manufacturing Market Size & Forecast, By Packaging Format, 2021 – 2032
9.6.6.6.4 Unit Dose Manufacturing Market Size & Forecast, By End User, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 Catalent, Inc.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Recipharm AB
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 PCI Pharma Services
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Aenova Group
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Sharp Services, LLC
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Unither Pharmaceuticals
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Vetter Pharma International GmbH
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Baxter BioPharma Solutions
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Lonza Group Ltd.
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Siegfried Holding AG
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Alcami Corporation
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 DPT Laboratories
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Klocke Group
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Tapemark
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 PillPack
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 AptarGroup, Inc.
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Stevanato Group
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Glenmark Life Sciences
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Sanofi Contract Manufacturing
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 CordenPharma
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Key Segments:
By Product
-
Liquid Unit Dose
-
Solid Unit Dose
-
Others
By Sourcing
-
In-house
-
Outsourcing
By Packaging Format
-
Blister & Strip Packs
-
Sachets, Pouches & Bottles
-
Parenteral & Specialized Containers
By End User
-
Independent Pharmacies
-
Long Term Care Facility
-
Hospitals
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
ASEAN Countries
-
Australia
-
Rest of Asia Pacific
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
